1. “Life or death for a young child too often depends on whether he is born in a country where vaccines are available or not” 2. accines: All the things considered 3.…

1.NEW DRUG DEVELOPMEN T Moderator – Dr.Amitabh kumar , Professor Presenter – Dr.Sriharsha Rayam 2. INTRODUCTION • Average time to develop new drug is 10 -12 years.…

1. Opexa Therapeutics, Inc. NASDAQ: OPXA Precision Immunotherapy October 2014 The Woodlands, TX Precision Immunotherapy® 2. 2 Forward-Looking Statements All statements in…

1. SWATI SARIN 2. Benefit –risk ratio can be calculated Prediction of therapeutic index Therapeutic index= Maximum tolerated dose Minimum curative dose Smaller ratio, better…

M ET AB O LI S M CL I NI CA L A N D EX PE R IM EN T AL X X (2 0 1 1) XXX – XXX available at www.sciencedirect.com www.metabolismjournal.com Endogenous and diet-induced…

1. Welcome to Ockham 2. Your Global Oncology Partner, Simplifying the Drug Development Process 3. Ockham was awarded CEO Cancer Gold Standard Accreditation on September 12,…

1. Clinical reflective practiceA group-based, situative approach to promote personal professional developmentA qualitative developmental evaluation 2. Background Aim of the…

PowerPoint Presentation Reaxys Medicinal Chemistry 1 Drug Repositioning (Repurposing) Christine Flemming [email protected] Webinar held November 20, 2014 1 2 Drug repurposing…

This document provides an outline of a presentation and is incomplete without the accompanying oral commentary and discussion. Conclusions and/ or potential strategies contained…

1. Clinical Trial Simulation Tool for Alzheimer’s Disease Klaus Romero MD MS FCP Director of Clinical Pharmacology Critical Path Institute 2. Why do drug development programs…